MagDI U.S. Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age22+
SponsorGT Metabolic Solutions, Inc.
About this trial
Assess the incidence and severity of internal hernia and bowel obstruction at one year in a U.S. population following use of the MagDI System to create side-to-side duodeno-ileal anastomoses.
Eligibility criteria
Qualifiers
>21 years of age, at the time of informed consent.
Body Mass Index (BMI) between 30-50 kg/m2.
Indicated for a side-to-side duodeno-ileal anastomosis and is treated with the MagDI System at a U.S. registry center.
Participant has been informed of the nature of the registry.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Side-to-side duodenal-ileal anastomosis
Treatment groups
106 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov